Market Cap 113.91M
Revenue (ttm) 27.47M
Net Income (ttm) -26.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -96.83%
Debt to Equity Ratio 0.00
Volume 454,451
Avg Vol 133,040
Day's Range N/A - N/A
Shares Out 4.20M
Stochastic %K 18%
Beta 2.47
Analysts Strong Sell
Price Target $98.39

Company Profile

Cue Biopharma, Inc., a clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders. The company's lead asset is CUE-221, an anti-IgE antibody with a dual-mechanism of action currently in Phase 2 development for allergic diseases. It also developed the Immuno-STAT platform, which targets disease-specific T cells in vivo without broad immune modulation. The company's lead autoimmune candidate is CUE-401, a bifunctional IL-2 and TGF-B program that is adv...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 949 2680
Address:
40 Guest Street, Boston, United States
Doom_Gloom_AR
Doom_Gloom_AR Aug. 11 at 3:11 AM
On this 10th day of August 2026 I purchased some $CUE about 5% of port. Good luck, ige differentiation is needed. Scientifically has a chance there are no guarantees in this business.
0 · Reply
OnlyFibs
OnlyFibs Aug. 10 at 10:49 PM
Cue Biopharma, Inc. $CUE (8h) Bullish Flow: Retail paper is getting shaken out while heavy-pocketed buyers scoop every dip along the lower trendline. Big bids are stacking up at the floor, laying the foundation for a massive secondary expansion wave. 🐂 💧 Bull Key Level: $25.97 (Bull confirmation to smash local channel resistance and trigger a high-velocity squeeze) 🐂 🔥 Bear Key Level: $22.50 (Key structural floor and critical multi-week demand zone to defend) 🐻 ⚠️ Targets: $35.00 / $45.52 💰 🍺 Why: The 8-hour chart is coiling like a springboard right on top of a massive volume shelf. Holding $22.50 keeps this ascending wedge primed for a violent rip through $35.00 straight up to $45.52. #cue | #cuebiopharma | #healthcare | #stocktrading | #hovdid
0 · Reply
ajmrtxl
ajmrtxl Aug. 7 at 6:33 PM
$CUE 's latest data on SqueezeFinder
0 · Reply
jigsaw76
jigsaw76 Aug. 4 at 6:17 PM
$CUE easy $80+
0 · Reply
theivanhoff
theivanhoff Aug. 2 at 8:24 PM
0 · Reply
Relee187200
Relee187200 Jul. 31 at 3:45 PM
$CUE Why down today? Any news?
0 · Reply
jigsaw76
jigsaw76 Jul. 30 at 10:23 PM
$CUE WTF IS THIS SHIT IM CRASHING OUT DO SOMZTHING SHITSTAIN SHITSTOCK
0 · Reply
jigsaw76
jigsaw76 Jul. 23 at 10:48 AM
$CUE this ticker needs more attention
0 · Reply
daprinta
daprinta Jul. 21 at 9:52 PM
$CUE …nah…Sir Douche-bag11…ur shot & ur fired…I’ll sell u a small piece of my stock @ $60 & u’ll thx me;capiche!!!
1 · Reply
daprinta
daprinta Jul. 21 at 12:02 PM
$CUE conventional wisdom is not applicable here… The smartest and largest shareholders are extremely confident & will not sell a single share @ these levels…now…w/far less shares outstanding & ..a float that is owned/controlled …there’s virtually only 1way2 go☝️
0 · Reply
Latest News on CUE
Cue Biopharma appoints James Ahlers as CFO

2026-08-03T13:05:29.000Z - 8 days ago

Cue Biopharma appoints James Ahlers as CFO


Cue Biopharma Announces $50.0 Million Private Placement

Jul 9, 2026, 9:40 PM EDT - 4 weeks ago

Cue Biopharma Announces $50.0 Million Private Placement


Cue Biopharma Registration statement: Registration filing

Jun 18, 2026, 8:00 AM EDT - 7 weeks ago

Cue Biopharma Registration statement: Registration filing


Cue Biopharma Slides: FY 2026

Jun 3, 2026, 3:10 PM EDT - 2 months ago

Cue Biopharma Slides: FY 2026


Cue Biopharma Registration statement: Registration filing

Jun 3, 2026, 8:00 AM EDT - 2 months ago

Cue Biopharma Registration statement: Registration filing


Cue Biopharma Transcript: EGM 2026

Jun 1, 2026, 9:00 AM EDT - 2 months ago

Cue Biopharma Transcript: EGM 2026


Cue Biopharma Proxy statement: Proxy filing

May 21, 2026, 8:00 AM EDT - 2 months ago

Cue Biopharma Proxy statement: Proxy filing


Cue Biopharma Quarterly report: Q1 2026

May 14, 2026, 7:00 AM EDT - 3 months ago

Cue Biopharma Quarterly report: Q1 2026


Cue Biopharma Earnings release: Q1 2026

May 14, 2026, 7:00 AM EDT - 3 months ago

Cue Biopharma Earnings release: Q1 2026


Cue Biopharma Proxy statement: Proxy filing

May 11, 2026, 8:00 AM EDT - 3 months ago

Cue Biopharma Proxy statement: Proxy filing


Cue Biopharma trading resumes

2026-05-04T17:37:20.000Z - 3 months ago

Cue Biopharma trading resumes


Cue Biopharma trading halted, volatility trading pause

2026-05-04T17:31:09.000Z - 3 months ago

Cue Biopharma trading halted, volatility trading pause


Why Is Cue Biopharma Stock Up Today?

2026-05-01T12:53:12.000Z - 3 months ago

Why Is Cue Biopharma Stock Up Today?


Cue Biopharma appoints Shao-Lee Lin as CEO

2026-04-30T21:13:55.000Z - 3 months ago

Cue Biopharma appoints Shao-Lee Lin as CEO


Cue Biopharma announces $30M private placement

2026-04-30T21:04:54.000Z - 3 months ago

Cue Biopharma announces $30M private placement


Cue Biopharma Announces $30 Million Private Placement

Apr 30, 2026, 4:25 PM EDT - 3 months ago

Cue Biopharma Announces $30 Million Private Placement


Cue Biopharma trading halted, volatility trading pause

2026-04-28T13:54:10.000Z - 3 months ago

Cue Biopharma trading halted, volatility trading pause


Cue Biopharma trading resumes

2026-04-28T13:48:36.000Z - 3 months ago

Cue Biopharma trading resumes


Cue Biopharma trading resumes

2026-04-27T14:37:18.000Z - 3 months ago

Cue Biopharma trading resumes


Cue Biopharma trading halted, volatility trading pause

2026-04-27T13:47:34.000Z - 3 months ago

Cue Biopharma trading halted, volatility trading pause


Cue Biopharma trading resumes

2026-04-24T13:48:28.000Z - 3 months ago

Cue Biopharma trading resumes


Cue Biopharma trading halted, volatility trading pause

2026-04-24T13:37:14.000Z - 3 months ago

Cue Biopharma trading halted, volatility trading pause


Cue Biopharma trading halted, news pending

2026-04-23T23:50:37.000Z - 3 months ago

Cue Biopharma trading halted, news pending


Cue Biopharma announces 1-for-30 reverse stock split

2026-04-22T14:15:23.000Z - 3 months ago

Cue Biopharma announces 1-for-30 reverse stock split


Cue Biopharma Announces 1-for-30 Reverse Stock Split

Apr 22, 2026, 8:37 AM EDT - 3 months ago

Cue Biopharma Announces 1-for-30 Reverse Stock Split


Cue Biopharma Transcript: AGM 2026

Apr 13, 2026, 9:00 AM EDT - 4 months ago

Cue Biopharma Transcript: AGM 2026


Cue Biopharma Transcript: R&D Day 2026

Apr 7, 2026, 10:00 AM EDT - 4 months ago

Cue Biopharma Transcript: R&D Day 2026


Cue Biopharma Slides: FY 2026

Apr 7, 2026, 10:00 AM EDT - 4 months ago

Cue Biopharma Slides: FY 2026


Cue Biopharma Announces CEO Transition

Mar 27, 2026, 4:05 PM EDT - 4 months ago

Cue Biopharma Announces CEO Transition


Cue Biopharma Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 4 months ago

Cue Biopharma Proxy statement: Proxy filing


Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026

Mar 26, 2026, 8:00 AM EDT - 4 months ago

Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026


Cue Biopharma Proxy statement: Proxy Filing

Mar 16, 2026, 8:00 AM EDT - 5 months ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Registration statement: Registration Filing

Mar 16, 2026, 8:00 AM EDT - 5 months ago

Cue Biopharma Registration statement: Registration Filing


Cue Biopharma Annual report: Q4 2025

Mar 16, 2026, 7:00 AM EDT - 5 months ago

Cue Biopharma Annual report: Q4 2025


Cue Biopharma Earnings release: Q4 2025

Mar 16, 2026, 7:00 AM EDT - 5 months ago

Cue Biopharma Earnings release: Q4 2025


Cue Biopharma Annual report: Q4 2025

Mar 16, 2026, 7:00 AM EDT - 5 months ago

Cue Biopharma Annual report: Q4 2025


Cue Biopharma Proxy statement: Proxy Filing

Mar 6, 2026, 7:00 AM EST - 5 months ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Announces Pricing of $10 Million Public Offering

Dec 19, 2025, 8:00 AM EST - 8 months ago

Cue Biopharma Announces Pricing of $10 Million Public Offering


Cue Biopharma Announces Proposed Public Offering

Dec 18, 2025, 4:02 PM EST - 8 months ago

Cue Biopharma Announces Proposed Public Offering


Cue Biopharma Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 9 months ago

Cue Biopharma Earnings release: Q3 2025


Cue Biopharma Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 9 months ago

Cue Biopharma Quarterly report: Q3 2025


Cue Biopharma Quarterly report: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 1 year ago

Cue Biopharma Quarterly report: Q2 2025


Cue Biopharma Earnings release: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 1 year ago

Cue Biopharma Earnings release: Q2 2025


Cue Biopharma Proxy statement: Proxy Filing

May 27, 2025, 8:00 AM EDT - 1 year ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Transcript: Status Update

May 15, 2025, 11:00 AM EDT - 1 year ago

Cue Biopharma Transcript: Status Update


Cue Biopharma Earnings release: Q1 2025

May 12, 2025, 4:00 PM EDT - 1 year ago

Cue Biopharma Earnings release: Q1 2025


Cue Biopharma Quarterly report: Q1 2025

May 12, 2025, 4:00 PM EDT - 1 year ago

Cue Biopharma Quarterly report: Q1 2025


Cue Biopharma to Host Virtual Investor Event on May 15, 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Cue Biopharma to Host Virtual Investor Event on May 15, 2025


Cue Biopharma Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Transcript: Status Update

Apr 15, 2025, 4:30 PM EDT - 1 year ago

Cue Biopharma Transcript: Status Update


Cue Biopharma to Host Business Update Call and Webcast

Apr 14, 2025, 5:02 PM EDT - 1 year ago

Cue Biopharma to Host Business Update Call and Webcast


Cue Biopharma Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Earnings release: Q4 2024

Mar 31, 2025, 12:00 AM EDT - 1 year ago

Cue Biopharma Earnings release: Q4 2024


Cue Biopharma Annual report: Q4 2024

Mar 31, 2025, 12:00 AM EDT - 1 year ago

Cue Biopharma Annual report: Q4 2024


Cue Biopharma Transcript: Stifel 2024 Healthcare Conference

Nov 19, 2024, 1:15 PM EST - 1 year ago

Cue Biopharma Transcript: Stifel 2024 Healthcare Conference


Cue Biopharma Announces Strategic Organizational Transition

Nov 14, 2024, 8:00 AM EST - 1 year ago

Cue Biopharma Announces Strategic Organizational Transition


Cue Biopharma Earnings release: Q3 2024

Nov 14, 2024, 12:00 AM EST - 1 year ago

Cue Biopharma Earnings release: Q3 2024


Cue Biopharma Quarterly report: Q3 2024

Nov 14, 2024, 12:00 AM EST - 1 year ago

Cue Biopharma Quarterly report: Q3 2024


Cue Biopharma Announces Proposed Public Offering

Sep 26, 2024, 11:10 PM EDT - 2 years ago

Cue Biopharma Announces Proposed Public Offering


Cue Biopharma Proxy statement: Proxy Filing

Sep 10, 2024, 8:00 AM EDT - 2 years ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Proxy statement: Proxy Filing

Aug 28, 2024, 8:00 AM EDT - 2 years ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Earnings Call Transcript: Q2 2024

Aug 19, 2024, 4:30 PM EDT - 2 years ago

Cue Biopharma Earnings Call Transcript: Q2 2024


Cue Biopharma Quarterly report: Q2 2024

Aug 19, 2024, 4:30 PM EDT - 2 years ago

Cue Biopharma Quarterly report: Q2 2024


Cue Biopharma Earnings release: Q2 2024

Aug 19, 2024, 4:30 PM EDT - 2 years ago

Cue Biopharma Earnings release: Q2 2024


Cue Biopharma Proxy statement: Proxy Filing

May 24, 2024, 8:00 AM EDT - 2 years ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Quarterly report: Q1 2024

May 9, 2024, 4:00 PM EDT - 2 years ago

Cue Biopharma Quarterly report: Q1 2024


Cue Biopharma Earnings release: Q1 2024

May 9, 2024, 4:00 PM EDT - 2 years ago

Cue Biopharma Earnings release: Q1 2024


Cue Biopharma Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Cue Biopharma Proxy statement: Proxy Filing


Cue Biopharma Earnings Call Transcript: Q4 2023

Apr 8, 2024, 4:30 PM EDT - 2 years ago

Cue Biopharma Earnings Call Transcript: Q4 2023


Cue Biopharma Earnings release: Q4 2023

Apr 8, 2024, 4:30 PM EDT - 2 years ago

Cue Biopharma Earnings release: Q4 2023


Cue Biopharma Annual report: Q4 2023

Apr 8, 2024, 4:30 PM EDT - 2 years ago

Cue Biopharma Annual report: Q4 2023


Cue Biopharma Slides: Investor Presentation

Apr 8, 2024, 10:00 AM EDT - 2 years ago

Cue Biopharma Slides: Investor Presentation


Doom_Gloom_AR
Doom_Gloom_AR Aug. 11 at 3:11 AM
On this 10th day of August 2026 I purchased some $CUE about 5% of port. Good luck, ige differentiation is needed. Scientifically has a chance there are no guarantees in this business.
0 · Reply
OnlyFibs
OnlyFibs Aug. 10 at 10:49 PM
Cue Biopharma, Inc. $CUE (8h) Bullish Flow: Retail paper is getting shaken out while heavy-pocketed buyers scoop every dip along the lower trendline. Big bids are stacking up at the floor, laying the foundation for a massive secondary expansion wave. 🐂 💧 Bull Key Level: $25.97 (Bull confirmation to smash local channel resistance and trigger a high-velocity squeeze) 🐂 🔥 Bear Key Level: $22.50 (Key structural floor and critical multi-week demand zone to defend) 🐻 ⚠️ Targets: $35.00 / $45.52 💰 🍺 Why: The 8-hour chart is coiling like a springboard right on top of a massive volume shelf. Holding $22.50 keeps this ascending wedge primed for a violent rip through $35.00 straight up to $45.52. #cue | #cuebiopharma | #healthcare | #stocktrading | #hovdid
0 · Reply
ajmrtxl
ajmrtxl Aug. 7 at 6:33 PM
$CUE 's latest data on SqueezeFinder
0 · Reply
jigsaw76
jigsaw76 Aug. 4 at 6:17 PM
$CUE easy $80+
0 · Reply
theivanhoff
theivanhoff Aug. 2 at 8:24 PM
0 · Reply
Relee187200
Relee187200 Jul. 31 at 3:45 PM
$CUE Why down today? Any news?
0 · Reply
jigsaw76
jigsaw76 Jul. 30 at 10:23 PM
$CUE WTF IS THIS SHIT IM CRASHING OUT DO SOMZTHING SHITSTAIN SHITSTOCK
0 · Reply
jigsaw76
jigsaw76 Jul. 23 at 10:48 AM
$CUE this ticker needs more attention
0 · Reply
daprinta
daprinta Jul. 21 at 9:52 PM
$CUE …nah…Sir Douche-bag11…ur shot & ur fired…I’ll sell u a small piece of my stock @ $60 & u’ll thx me;capiche!!!
1 · Reply
daprinta
daprinta Jul. 21 at 12:02 PM
$CUE conventional wisdom is not applicable here… The smartest and largest shareholders are extremely confident & will not sell a single share @ these levels…now…w/far less shares outstanding & ..a float that is owned/controlled …there’s virtually only 1way2 go☝️
0 · Reply
daprinta
daprinta Jul. 21 at 11:50 AM
$CUE be very careful…”plenty of room to go down”…how about unlimited upside that will be fueled by ppl/U…scrabbling to buyback…thus, the proverbial; SHORT SQUEEZE! Fair warning to brace yourself
1 · Reply
jigsaw76
jigsaw76 Jul. 20 at 11:06 PM
$CUE went all in
0 · Reply
jigsaw76
jigsaw76 Jul. 20 at 5:56 PM
$CUE need a big shot to tweet about this and bring in some volume, easy 2x
0 · Reply
AC_TRADER
AC_TRADER Jul. 20 at 3:35 PM
$CUE Some lvls t I made with @TrendSpider https://share.trendspider.com/chart/CUE/7594tdyr75
0 · Reply
jigsaw76
jigsaw76 Jul. 17 at 5:47 PM
0 · Reply
Dr_Stoxx
Dr_Stoxx Jul. 16 at 4:54 PM
Our 3 Momentum SHORTS this week. How are we doing? Momentum Letter: our most profitable service since 2015. $DWSN $CUE $PENG
0 · Reply
jigsaw76
jigsaw76 Jul. 16 at 1:57 PM
$CUE wouldn't give a fuck if it went to 0
0 · Reply
jigsaw76
jigsaw76 Jul. 14 at 12:38 PM
$CUE relax and take some sip of cola 👍
0 · Reply
Relee187200
Relee187200 Jul. 13 at 6:29 PM
$CUE Damn!!
1 · Reply